共 106 条
[1]
Ntali G(2018)Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas Pituitary 21 111-118
[2]
Wass JA(2006)High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège, Belgium J Clin Endocrinol Metab 91 4769-4775
[3]
Daly AF(2022)Overview of the 2022 WHO classification of pituitary adenomas/pituitary neuroendocrine tumors: clinical practices, controversies, and perspectives Curr Med Sci 42 1111-1118
[4]
Rixhon M(2018)Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 Eur J Endocrinol 178 265-276
[5]
Adam C(2010)Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas Clin Endocrinol (Oxf) 72 648-653
[6]
Dempegioti A(2020)Aggressive pituitary tumors in the young and elderly Rev Endocr Metab Disord 21 213-223
[7]
Tichomirowa MA(2021)Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence J Neurosurg 135 1706-1713
[8]
Beckers A(2014)Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas Clin Endocrinol (Oxf) 81 566-572
[9]
Wan X-Y(2018)Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery Eur Radiol 28 3692-3701
[10]
Chen J(2022)Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas Eur Radiol 32 1570-1578